Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Hum Vaccin Immunother
المؤلفون الرئيسيون: Valéa, Innocent, Adjei, Samuel, Usuf, Effua, Traore, Ousmane, Ansong, Daniel, Tinto, Halidou, Owusu Boateng, Harry, Leach, Amanda, Mwinessobaonfou Some, Athanase, Buabeng, Patrick, Vekemans, Johan, Nana, Louis Arnaud, Kotey, Amos, Vandoolaeghe, Pascale, Ouedraogo, Florence, Sambian, David, Lievens, Marc, Tahita, Marc Christian, Rettig, Theresa, Jongert, Erik, Lompo, Palpouguini, Idriss, Ali, Borys, Dorota, Ouedraogo, Sayouba, Prempeh, Frank, Habib, Md Ahsan, Schuerman, Lode, Sorgho, Hermann, Agbenyega, Tsiri
التنسيق: Artigo
اللغة:Inglês
منشور في: Taylor & Francis 2018
الموضوعات:
Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037440/
https://ncbi.nlm.nih.gov/pubmed/29630438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1442996
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة